KIDS
OrthoPediatrics Corp.
Price Chart
Latest Quote
$19.62
| Previous Close | $19.14 |
| Open | $19.14 |
| Day High | $19.67 |
| Day Low | $19.14 |
| Volume | 144,374 |
Stock Information
| Shares Outstanding | 25.68M |
| Total Debt | $112.20M |
| Cash Equivalents | $48.81M |
| Revenue | $243.30M |
| Net Income | $-39.68M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $503.94M |
| EPS (TTM) | $-1.68 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $567.33M |
| Sales | $243.30M |
| Income | $-39.68M |
| Book/sh | $13.23 |
| Cash/sh | $1.90 |
| Employees | 602 |
Financial Ratios
| Quick Ratio | 2.19 |
| Current Ratio | 5.21 |
| Debt/Eq | 33.12 |
Returns & Margins
| ROA | -3.39% |
| ROE | -11.57% |
| Gross Margin | 73.07% |
| Operating Margin | -14.04% |
| Profit Margin | -16.31% |
Ownership
| Insider Ownership | 32.85% |
| Institutional Ownership | 66.98% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -28.85 |
| P/S | 2.07 |
| P/B | 1.48 |
Analyst Data
| Recommendation | buy |
| Target Price | $24.67 |
Technical Indicators
| SMA20 | $18.08 |
| SMA50 | $17.43 |
| SMA200 | $17.56 |
| RSI | 64.67 |
| ATR | 0.7098 |
| Shares Float | 17.08M |
| Short Float | 5.26% |
| Short Ratio | 5.10 |
| Volatility | 1.01 |
| Rel Volume | 1.18 |
Performance History
| Week | +7.98% |
| Month | +9.61% |
| Quarter | +20.89% |
| 6 Months | +13.02% |
| YTD | +11.73% |
| Year | -8.45% |
| 3 Years | -57.55% |
| 5 Years | -69.35% |
| 10 Years | +4.64% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $19.62 | 146,656 |
| 2026-06-24 | $19.14 | 200,400 |
| 2026-06-23 | $18.38 | 130,400 |
| 2026-06-22 | $18.16 | 61,200 |
| 2026-06-18 | $18.87 | 140,500 |
| 2026-06-17 | $18.17 | 144,600 |
| 2026-06-16 | $18.53 | 65,100 |
| 2026-06-15 | $18.15 | 164,100 |
| 2026-06-12 | $17.82 | 96,200 |
| 2026-06-11 | $17.83 | 76,400 |
| 2026-06-10 | $18.46 | 95,600 |
| 2026-06-09 | $18.49 | 105,300 |
| 2026-06-08 | $18.23 | 90,300 |
| 2026-06-05 | $18.32 | 93,700 |
| 2026-06-04 | $18.10 | 155,100 |
| 2026-06-03 | $16.92 | 193,000 |
| 2026-06-02 | $16.81 | 124,200 |
| 2026-06-01 | $16.65 | 174,400 |
| 2026-05-29 | $17.17 | 148,000 |
| 2026-05-28 | $17.81 | 76,500 |
| 2026-05-27 | $17.55 | 91,600 |
| 2026-05-26 | $17.90 | 116,200 |
About OrthoPediatrics Corp.
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
đ° Latest News
OrthoPediatrics (KIDS) Stock Sees Split Analyst Revisions After Mixed Price Target Changes
Simply Wall St. âĸ 2026-06-25T12:06:40ZWhy The OrthoPediatrics (KIDS) Narrative Is Evolving Without A New Price Target
Simply Wall St. âĸ 2026-06-08T14:09:25ZHow The OrthoPediatrics (KIDS) Story Is Shifting As Analysts Reassess Growth And Valuation
Simply Wall St. âĸ 2026-05-25T07:07:04ZIs the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?
Insider Monkey âĸ 2026-05-13T09:42:33ZOrthoPediatrics Corp (KIDS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2026-05-01T07:19:39ZOrthoPediatrics (KIDS) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-01T01:30:51ZOrthoPediatrics Corp. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-01T00:46:34ZOrthoPediatrics Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-01T00:09:40ZOrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks âĸ 2026-04-30T22:30:02ZOrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-04-30T22:25:11ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $63,687,000 | $56,129,000 | $37,479,000 | $31,629,000 |
| Cost Of Revenue | $63,687,000 | $56,129,000 | $37,479,000 | $31,629,000 |
| Total Revenue | $236,348,000 | $204,727,000 | $148,732,000 | $122,289,000 |
| Operating Revenue | $236,348,000 | $204,727,000 | $148,732,000 | $122,289,000 |
| Expenses | ||||
| Total Expenses | $265,347,000 | $234,248,000 | $174,498,000 | $144,079,000 |
| Other Income Expense | $-4,193,000 | $-9,787,000 | $4,256,000 | $20,525,000 |
| Other Non Operating Income Expenses | $6,046,000 | $-1,068,000 | $2,261,000 | $-1,796,000 |
| Net Non Operating Interest Income Expense | $-5,996,000 | $-2,621,000 | $198,000 | $-2,424,000 |
| Total Other Finance Cost | $5,996,000 | $2,621,000 | $-198,000 | $2,424,000 |
| Operating Expense | $201,660,000 | $178,119,000 | $137,019,000 | $112,450,000 |
| Selling And Marketing Expense | $72,726,000 | $64,296,000 | $52,824,000 | $46,094,000 |
| General And Administrative Expense | $119,832,000 | $102,789,000 | $73,300,000 | $57,904,000 |
| Interest Expense | - | - | - | $2,424,000 |
| Interest Expense Non Operating | - | - | - | $2,424,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-39,648,000 | $-37,822,000 | $-20,974,000 | $1,258,000 |
| Net Interest Income | $-5,996,000 | $-2,621,000 | $198,000 | $-2,424,000 |
| Normalized Income | $-31,559,190 | $-29,957,462 | $-22,937,080 | $-16,375,590 |
| Net Income From Continuing And Discontinued Operation | $-39,648,000 | $-37,822,000 | $-20,974,000 | $1,258,000 |
| Total Operating Income As Reported | $-39,238,000 | $-35,010,000 | $-26,751,000 | $-25,399,000 |
| Net Income Common Stockholders | $-39,648,000 | $-37,822,000 | $-20,974,000 | $1,235,000 |
| Net Income | $-39,648,000 | $-37,822,000 | $-20,974,000 | $1,258,000 |
| Net Income Including Noncontrolling Interests | $-39,648,000 | $-37,822,000 | $-20,974,000 | $1,258,000 |
| Net Income Continuous Operations | $-39,648,000 | $-37,822,000 | $-20,974,000 | $1,258,000 |
| Pretax Income | $-39,188,000 | $-41,929,000 | $-21,312,000 | $-3,689,000 |
| Special Income Charges | $-10,239,000 | $-8,719,000 | $1,995,000 | $22,321,000 |
| Operating Income | $-28,999,000 | $-29,521,000 | $-25,766,000 | $-21,790,000 |
| Gross Profit | $172,661,000 | $148,598,000 | $111,253,000 | $90,660,000 |
| Net Income Discontinuous Operations | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-1.69 | $-1.64 | $-0.92 | $0.06 |
| Basic EPS | $-1.69 | $-1.64 | $-0.92 | $0.06 |
| Other | ||||
| Tax Effect Of Unusual Items | $-2,150,190 | $-854,462 | $31,920 | $4,687,410 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $2,359,000 | $-1,722,000 | $-10,376,000 | $-31,012,000 |
| Total Unusual Items | $-10,239,000 | $-8,719,000 | $1,995,000 | $22,321,000 |
| Total Unusual Items Excluding Goodwill | $-10,239,000 | $-8,719,000 | $1,995,000 | $22,321,000 |
| Reconciled Depreciation | $21,119,000 | $19,080,000 | $17,385,000 | $13,099,000 |
| EBITDA (Bullshit earnings) | $-7,880,000 | $-10,441,000 | $-8,381,000 | $-8,691,000 |
| EBIT | $-28,999,000 | $-29,521,000 | $-25,766,000 | $-21,790,000 |
| Diluted Average Shares | $23,459,425 | $23,077,704 | $22,675,477 | $20,947,727 |
| Basic Average Shares | $23,459,425 | $23,077,704 | $22,675,477 | $20,704,556 |
| Diluted NI Availto Com Stockholders | $-39,648,000 | $-37,822,000 | $-20,974,000 | $1,235,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $23,000 |
| Tax Provision | $460,000 | $-4,107,000 | $-338,000 | $-4,947,000 |
| Impairment Of Capital Assets | $4,638,000 | $1,836,000 | $985,000 | $3,609,000 |
| Restructuring And Mergern Acquisition | $5,601,000 | $3,653,000 | $-2,980,000 | $-25,930,000 |
| Research And Development | $9,102,000 | $11,034,000 | $10,895,000 | $8,452,000 |
| Selling General And Administration | $192,558,000 | $167,085,000 | $126,124,000 | $103,998,000 |
| Other Gand A | $119,832,000 | $102,789,000 | $73,300,000 | $57,904,000 |
| Other Special Charges | - | $3,230,000 | - | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $159,616,000 | $179,543,000 | $208,764,000 | $211,926,000 |
| Total Assets | $508,630,000 | $473,209,000 | $438,745,000 | $427,727,000 |
| Total Non Current Assets | $252,211,000 | $236,036,000 | $212,249,000 | $201,008,000 |
| Other Non Current Assets | $15,676,000 | $10,417,000 | $2,940,000 | - |
| Goodwill And Other Intangible Assets | $186,980,000 | $175,023,000 | $168,261,000 | $166,722,000 |
| Other Intangible Assets | $77,711,000 | $81,179,000 | $84,562,000 | $79,901,000 |
| Current Assets | $256,419,000 | $237,173,000 | $226,496,000 | $226,719,000 |
| Other Current Assets | $5,876,000 | $7,021,000 | $3,750,000 | $3,966,000 |
| Restricted Cash | $2,064,000 | $1,957,000 | $1,972,000 | $1,471,000 |
| Inventory | $133,790,000 | $117,005,000 | $105,851,000 | $78,192,000 |
| Receivables | $53,838,000 | $42,357,000 | $34,617,000 | $24,800,000 |
| Accounts Receivable | $53,838,000 | $42,357,000 | $34,617,000 | $24,800,000 |
| Allowance For Doubtful Accounts Receivable | $-1,501,000 | $-1,145,000 | $-1,373,000 | $-1,056,000 |
| Gross Accounts Receivable | $55,339,000 | $43,502,000 | $35,990,000 | $25,856,000 |
| Cash Cash Equivalents And Short Term Investments | $60,851,000 | $68,833,000 | $80,306,000 | $118,290,000 |
| Cash And Cash Equivalents | $19,556,000 | $43,820,000 | $31,055,000 | $8,991,000 |
| Cash Financial | $19,556,000 | $43,820,000 | $31,055,000 | $8,991,000 |
| Prepaid Assets | - | - | - | $3,966,000 |
| Notes Receivable | - | - | - | - |
| Debt | ||||
| Net Debt | $80,434,000 | $29,296,000 | - | - |
| Total Debt | $99,990,000 | $73,116,000 | $10,060,000 | $907,000 |
| Long Term Debt And Capital Lease Obligation | $99,820,000 | $72,956,000 | $9,908,000 | $763,000 |
| Long Term Debt | $99,820,000 | $72,956,000 | $9,908,000 | $763,000 |
| Current Debt And Capital Lease Obligation | $170,000 | $160,000 | $152,000 | $144,000 |
| Current Debt | $170,000 | $160,000 | $152,000 | $144,000 |
| Other Current Borrowings | $170,000 | $160,000 | $152,000 | $144,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $162,034,000 | $118,643,000 | $61,720,000 | $49,079,000 |
| Total Non Current Liabilities Net Minority Interest | $115,837,000 | $84,681,000 | $20,054,000 | $18,208,000 |
| Other Non Current Liabilities | $9,537,000 | $5,892,000 | $1,112,000 | $3,472,000 |
| Tradeand Other Payables Non Current | $2,898,000 | $2,452,000 | $3,551,000 | $8,019,000 |
| Non Current Deferred Liabilities | $3,582,000 | $3,381,000 | $5,483,000 | $5,954,000 |
| Non Current Deferred Taxes Liabilities | $3,582,000 | $3,381,000 | $5,483,000 | $5,954,000 |
| Current Liabilities | $46,197,000 | $33,962,000 | $41,666,000 | $30,871,000 |
| Other Current Liabilities | $11,354,000 | $9,659,000 | $7,391,000 | $5,018,000 |
| Payables And Accrued Expenses | $29,392,000 | $17,775,000 | $29,844,000 | $22,427,000 |
| Payables | $20,980,000 | $10,255,000 | $22,798,000 | $18,965,000 |
| Other Payable | $2,194,000 | $1,347,000 | $10,149,000 | $7,815,000 |
| Accounts Payable | $18,786,000 | $8,908,000 | $12,649,000 | $11,150,000 |
| Equity | ||||
| Common Stock Equity | $346,596,000 | $354,566,000 | $377,025,000 | $378,648,000 |
| Total Equity Gross Minority Interest | $346,596,000 | $354,566,000 | $377,025,000 | $378,648,000 |
| Stockholders Equity | $346,596,000 | $354,566,000 | $377,025,000 | $378,648,000 |
| Gains Losses Not Affecting Retained Earnings | $-523,000 | $-10,773,000 | $-5,526,000 | $-5,400,000 |
| Other Equity Adjustments | $-523,000 | $-10,773,000 | $-5,526,000 | $-5,400,000 |
| Retained Earnings | $-275,212,000 | $-235,564,000 | $-197,742,000 | $-176,768,000 |
| Other | ||||
| Ordinary Shares Number | $25,093,792 | $24,217,508 | $23,378,408 | $22,877,962 |
| Share Issued | $25,093,792 | $24,217,508 | $23,378,408 | $22,877,962 |
| Tangible Book Value | $159,616,000 | $179,543,000 | $208,764,000 | $211,926,000 |
| Invested Capital | $446,586,000 | $427,682,000 | $387,085,000 | $379,555,000 |
| Working Capital | $210,222,000 | $203,211,000 | $184,830,000 | $195,848,000 |
| Total Capitalization | $446,416,000 | $427,522,000 | $386,933,000 | $379,411,000 |
| Additional Paid In Capital | $622,325,000 | $600,897,000 | $580,287,000 | $560,810,000 |
| Capital Stock | $6,000 | $6,000 | $6,000 | $6,000 |
| Common Stock | $6,000 | $6,000 | $6,000 | $6,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,281,000 | $6,368,000 | $4,279,000 | $3,282,000 |
| Current Accrued Expenses | $8,412,000 | $7,520,000 | $7,046,000 | $3,462,000 |
| Goodwill | $109,269,000 | $93,844,000 | $83,699,000 | $86,821,000 |
| Net PPE | $49,555,000 | $50,596,000 | $41,048,000 | $34,286,000 |
| Accumulated Depreciation | $-57,865,000 | $-46,117,000 | $-39,588,000 | $-30,804,000 |
| Gross PPE | $107,420,000 | $96,713,000 | $80,636,000 | $65,090,000 |
| Construction In Progress | $8,271,000 | $7,342,000 | $5,519,000 | $3,719,000 |
| Other Properties | $72,117,000 | $64,297,000 | $55,873,000 | $46,270,000 |
| Machinery Furniture Equipment | $13,514,000 | $11,406,000 | $11,649,000 | $7,647,000 |
| Buildings And Improvements | $11,168,000 | $11,318,000 | $5,870,000 | $5,729,000 |
| Land And Improvements | $2,350,000 | $2,350,000 | $1,725,000 | $1,725,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $41,295,000 | $25,013,000 | $49,251,000 | $109,299,000 |
| Treasury Shares Number | - | - | $0 | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-15,961,000 | $-41,311,000 | $-43,924,000 | $-31,797,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,851,000 | $-27,048,000 | $-27,046,000 | $-21,766,000 |
| Cash Flow From Continuing Operating Activities | $-4,851,000 | $-27,048,000 | $-27,046,000 | $-21,766,000 |
| Operating Gains Losses | - | $3,230,000 | - | - |
| Cash From Discontinued Operating Activities | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-11,110,000 | $-14,263,000 | $-16,878,000 | $-10,031,000 |
| Investing Cash Flow | $-43,629,000 | $-13,162,000 | $41,677,000 | $-113,371,000 |
| Cash Flow From Continuing Investing Activities | $-43,629,000 | $-13,162,000 | $41,677,000 | $-113,371,000 |
| Net Other Investing Changes | - | - | $-546,000 | - |
| Financing Activities | ||||
| Financing Cash Flow | $23,975,000 | $53,135,000 | $7,301,000 | $135,974,000 |
| Cash Flow From Continuing Financing Activities | $23,975,000 | $53,135,000 | $7,301,000 | $135,974,000 |
| Net Other Financing Charges | $-867,000 | $-8,015,000 | $-2,000,000 | $-3,234,000 |
| Issuance Of Capital Stock | - | $0 | $0 | $139,282,000 |
| Net Common Stock Issuance | - | $0 | $0 | $139,282,000 |
| Common Stock Issuance | - | $0 | $0 | $139,282,000 |
| Other | ||||
| Repayment Of Debt | $-158,000 | $-12,383,000 | $-144,000 | $-31,137,000 |
| Issuance Of Debt | $25,000,000 | $73,533,000 | $9,424,000 | $31,000,000 |
| Interest Paid Supplemental Data | $6,516,000 | $2,752,000 | $42,000 | $700,000 |
| End Cash Position | $21,620,000 | $45,777,000 | $33,027,000 | $10,462,000 |
| Beginning Cash Position | $45,777,000 | $33,027,000 | $10,462,000 | $9,006,000 |
| Effect Of Exchange Rate Changes | $348,000 | $-175,000 | $633,000 | $619,000 |
| Changes In Cash | $-24,505,000 | $12,925,000 | $21,932,000 | $837,000 |
| Proceeds From Stock Option Exercised | $0 | $0 | $21,000 | $63,000 |
| Net Issuance Payments Of Debt | $24,842,000 | $61,150,000 | $9,280,000 | $-137,000 |
| Net Long Term Debt Issuance | $24,842,000 | $61,150,000 | $9,280,000 | $-137,000 |
| Long Term Debt Payments | $-158,000 | $-12,383,000 | $-144,000 | $-31,137,000 |
| Long Term Debt Issuance | $25,000,000 | $73,533,000 | $9,424,000 | $31,000,000 |
| Net Investment Purchase And Sale | $-17,017,000 | $24,208,000 | $62,198,000 | $-63,250,000 |
| Sale Of Investment | $0 | $49,855,000 | $112,904,000 | $46,872,000 |
| Purchase Of Investment | $-17,017,000 | $-25,647,000 | $-50,706,000 | $-110,122,000 |
| Net Business Purchase And Sale | $-15,502,000 | $-23,107,000 | $-3,097,000 | $-40,090,000 |
| Purchase Of Business | $-15,502,000 | $-23,107,000 | $-3,097,000 | $-40,090,000 |
| Net PPE Purchase And Sale | $-11,110,000 | $-14,263,000 | $-16,878,000 | $-10,031,000 |
| Purchase Of PPE | $-11,110,000 | $-14,263,000 | $-16,878,000 | $-10,031,000 |
| Change In Working Capital | $-10,792,000 | $-22,935,000 | $-32,197,000 | $-17,756,000 |
| Change In Other Working Capital | $-2,786,000 | $315,000 | $-4,631,000 | $536,000 |
| Change In Payables And Accrued Expense | $9,415,000 | $-3,743,000 | $8,343,000 | $3,135,000 |
| Change In Accrued Expense | $1,248,000 | $537,000 | $6,852,000 | $3,344,000 |
| Change In Payable | $8,167,000 | $-4,280,000 | $1,491,000 | $-209,000 |
| Change In Account Payable | $8,167,000 | $-4,280,000 | $1,491,000 | $-209,000 |
| Change In Prepaid Assets | $414,000 | $-1,561,000 | $94,000 | $-506,000 |
| Change In Inventory | $-8,469,000 | $-13,197,000 | $-26,279,000 | $-16,938,000 |
| Change In Receivables | $-9,366,000 | $-4,749,000 | $-9,724,000 | $-3,983,000 |
| Changes In Account Receivables | $-9,366,000 | $-4,749,000 | $-9,724,000 | $-3,983,000 |
| Other Non Cash Items | $333,000 | $751,000 | $-1,608,000 | $-23,623,000 |
| Stock Based Compensation | $17,778,000 | $13,548,000 | $10,526,000 | $6,679,000 |
| Asset Impairment Charge | $6,512,000 | $1,836,000 | $985,000 | $3,609,000 |
| Deferred Tax | $-153,000 | $-4,736,000 | $-1,163,000 | $-5,032,000 |
| Deferred Income Tax | $-153,000 | $-4,736,000 | $-1,163,000 | $-5,032,000 |
| Depreciation Amortization Depletion | $21,119,000 | $19,080,000 | $17,385,000 | $13,099,000 |
| Depreciation And Amortization | $21,119,000 | $19,080,000 | $17,385,000 | $13,099,000 |
| Net Income From Continuing Operations | $-39,648,000 | $-37,822,000 | $-20,974,000 | $1,258,000 |
| Net Intangibles Purchase And Sale | - | - | $-2,106,000 | $0 |
| Purchase Of Intangibles | - | - | $-2,106,000 | $0 |
| Amortization Cash Flow | - | - | $7,149,000 | $5,977,000 |
| Amortization Of Intangibles | - | - | $7,149,000 | $5,977,000 |
| Depreciation | - | - | $10,236,000 | $7,121,000 |